COVID-19 vaccines: challenges and solutions

被引：5

作者：

Mohseni Afshar, Zeinab ^{[1
]}

Babazadeh, Arefeh ^{[2
]}

Janbakhsh, Alireza ^{[1
]}

Afsharian, Mandana ^{[1
]}

Ebrahimpour, Soheil ^{[2
]}

机构：

[1] Kermanshah Univ Med Sci, Imam Reza Hosp, Clin Res Dev Ctr, Kermanshah, Iran

[2] Babol Univ Med Sci, Infect Dis & Trop Med Res Ctr, Hlth Res Inst, Babol, Iran

来源：

MINERVA RESPIRATORY MEDICINE | 2021年 / 60卷 / 04期

关键词：

SARS-CoV-2; COVID-19; Vaccines; DISEASE; 2019; COVID-19; NEED;

D O I：

10.23736/S2784-8477.21.01921-0

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a global emergency by the World Health Organization (WHO). Several ways have been used to control and manage the COVID-19 pandemic. Among them, development of vaccines could be an important breakthrough against novel virus. It is important to note that the candidate vaccine is expected to work against infection and transmission. To date, many COVID-19 vaccine clinical trials have been registered worldwide. However, some vaccine candidates could meet adequate standards for effectiveness and safety. In the current review, we discussed the effectiveness, safety, target population, and hesitancy of COVID-19 vaccines.

引用

页码：136 / 141

页数：6

共 50 条

[31] COVID-19 vaccines: modes of immune activation and future challenges
John R. Teijaro
Donna L. Farber
Nature Reviews Immunology, 2021, 21 : 195 - 197
[32] Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
Zhu, Congrui
Pang, Shengmei
Liu, Jiaqi
Duan, Qiangde
DRUGS, 2024, 84 (04) : 403 - 423
[33] COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects
Wong, Rebecca S. Y.
MALAYSIAN JOURNAL OF PATHOLOGY, 2021, 43 (02) : 203 - 217
[34] COVID-19 vaccines: where we stand and challenges ahead
Guido Forni
Alberto Mantovani
Cell Death & Differentiation, 2021, 28 : 626 - 639
[35] COVID-19 vaccines: modes of immune activation and future challenges
Teijaro, John R.
Farber, Donna L.
NATURE REVIEWS IMMUNOLOGY, 2021, 21 (04) : 195 - 197
[36] Innovations and Challenges in the Development of COVID-19 Vaccines for a Safer Tomorrow
Kumar, Devika S.
Prasanth, Krishna
Bhandari, Ashni
Jha, Vivek Kumar
Naveen, Avula
Prasanna, Muthu
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
[37] COVID-19 vaccines: Global challenges and prospects forum recommendations
Boudjelal, Mohamed
Almajed, Faisal
Salman, Ahmed M.
Alharbi, Naif K.
Colangelo, Margaretta
Michelotti, Julia M.
Olinger, Gene
Baker, Mariwan
Hill, Adrian V. S.
Alaskar, Ahmed
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 448 - 451
[38] Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19
Li, Qian
Wang, Jun
Tang, Yang
Lu, Hongzhou
DRUG DISCOVERIES AND THERAPEUTICS, 2021, 15 (03): : 118 - 123
[39] COVID-19 vaccines/immunosuppressantsLack of efficacy and COVID-19
Reactions Weekly, 2024, 2009 (1) : 188 - 188
[40] Dry Ice Standalone Solutions to Transport Covid-19 Vaccines
Kacimi, Abbes
Labranque, Gilles
Cavalier, Gerald
7TH IIR 2022 INTERNATIONAL CONFERENCE ON SUSTAINABILITY AND THE COLD CHAIN 2022, 2022, : 408 - 416

← 1 2 3 4 5 →